MannKind | MNKD - Активы





Активы Изменить Дата
Adma Biologics USD 684.21M 19.03M 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Insmed USD 2.1B 26.7M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 345.41M 127.54M 2026-06
MannKind USD 732.3M 12.1M 2026-06
Merck USD 129.8B 1.12B 2026-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Novavax USD 955.58M 87.59M 2026-06
Novo Nordisk DKK 90.92B 468.3B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Xencor USD 724.96M 11.89M 2026-06